Luly Jay R. 4
4 · ENANTA PHARMACEUTICALS INC · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Luly Jay R.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-02-12+5,400→ 812,193 total - Tax Payment
Common Stock
2024-02-12$12.41/sh−1,584$19,657→ 810,609 total
Footnotes (2)
- [F1]Represents shares of Enanta common stock issued under performance share units ("PSUs") that vested as a result of performance against two-year research and development milestones in the calendar 2022-2023 period as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2024.
- [F2]Represents the number of shares of common stock automatically forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU awards.